51³Ô¹ÏÍø

Tag - shire

 
 

SHIRE

Japan Times
BUSINESS / Companies
Jan 9, 2019
Takeda¡¯s CEO says it needs to sell assets quickly to cut debt
The sooner, the better.
Japan Times
BUSINESS
Jan 7, 2019
With nearly $900 billion in cash at the ready, Japan¡¯s M&A spending spree likely to continue
Japan outmuscled China to dominate mergers and acquisitions in Asia last year, and with companies in possession of more than $890 billion in cash, the spending spree is likely to continue in 2019.
Japan Times
BUSINESS / Companies / ANALYSIS
Dec 6, 2018
Takeda downgrade looms after shareholders approve Shire deal
Takeda Pharmaceutical Co. shareholders¡¯ approval of the $62 billion (about ?7 trillion) acquisition of Shire PLC is good news for its bosses¡¯ ambitions to build a global drug giant ¡ª but bad news for its credit ratings.
Japan Times
BUSINESS / Companies
Nov 6, 2018
Japan¡¯s Takeda Pharmaceutical pushes back as dissident shareholders seek to stop Shire deal
Takeda Pharmaceutical Co. Chief Executive Officer Christophe Weber pushed back against dissident shareholders seeking to stop the drugmaker¡¯s acquisition of Shire PLC, saying he won¡¯t release minutes of boardroom discussions.
Japan Times
BUSINESS / Companies
Oct 29, 2018
Takeda may sell some European over-the-counter assets as it seeks to slash debt
Takeda Pharmaceutical Co. is considering a sale of assets from its over-the-counter business in Europe, as the drugmaker pursues ways to cut debt after its $62 billion takeover of Shire PLC, people familiar with the matter said.
Japan Times
BUSINESS / Companies
Jul 18, 2018
Takeda bets on China for global growth, seeing the country as ¡®on a par¡¯ with the U.S. and Europe
Takeda Pharmaceutical Co. sees China becoming a ¡°core country¡± for its global growth strategy, and is optimistic its $62 billion (?6.94 trillion) acquisition of Shire PLC will win approval by the country¡¯s regulators.
BUSINESS / Companies
May 24, 2018
Takeda invites banks to join $31 billion loan for Shire deal
Takeda Pharmaceutical Co. has invited Japanese and overseas banks to participate in the syndication of the $30.85 billion (?3.362 trillion) loan to back its $62 billion purchase of Shire Plc, according to people familiar with the matter.
Japan Times
BUSINESS / Companies / ANALYSIS
Apr 26, 2018
Shire bid marks Takeda¡¯s latest and biggest push for global status
Takeda Pharmaceutical Co. Ltd..¡¯s $64 billion bid for London-listed rare-disease specialist Shire PLC bolsters its credentials as Japan¡¯s most outward-facing drugs firm, a mold-breaking image that has been more than a decade in the making.
BUSINESS / Companies
Apr 21, 2018
Japanese drugmaker Takeda adds more cash to Shire bid, sending offer past $60 billion
Takeda Pharmaceutical Co. sweetened its offer for drugmaker Shire PLC to more than $60 billion after three prior bids were rejected, wooing investors in the U.S. company with a higher cash component.
Japan Times
BUSINESS / Companies
Mar 29, 2018
Takeda shares slide amid $50 billion takeover bid for Shire
Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ?5.3 trillion), which would be the Japanese company¡¯s biggest takeover ever.

Longform

For many people, utility poles and power lines have become such a familiar part of Japan¡¯s landscape that they often go unnoticed.
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon

SUSTAINABLE 51³Ô¹ÏÍø